R1 RCM . with ticker code (RCM) have now 8 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 35 and 27.5 calculating the average target price we see 32.19. Now with the previous closing price of 25.56 this would indicate that there is a potential upside of 25.9%. The day 50 moving average is 24.31 and the 200 day moving average is 22.85. The company has a market cap of $7,193m. Find out more information at: https://www.r1rcm.com
The potential market cap would be $9,059m based on the market concensus.
R1 RCM . provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services, luding physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, luding charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, luding health systems, hospitals, and physician groups. The company was formerly known as Accretive Health and changed its name to R1 RCM . in January 2017. R1 RCM . was orporated in 2003 and is headquartered in Murray, Utah.
